Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Various portable screening technologies have been developed to assess the quality and authenticity of medicines and thereby combat the growing global problem of substandard and falsified (SF) medicines. However, the capabilities and limitations of many technologies are not well characterized, particularly when used outside the laboratory, for example in supply chain testing or at the point of care. This Stimuli article addresses the need for structured, effective approaches to performing a pragmatic review of a given technology. The information collected during the review can inform the selection and deployment of the technology of interest, which in turn can help prevent SF drugs from reaching vulnerable populations. Comments from the public and stakeholders are requested as this review will subsequently become a USP informational chapter (above <1000>).


Journal article


Pharmacopeial Forum

Publication Date